Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - AstraZeneca Pharma

AstraZeneca Pharma

BSE: 506820|NSE: ASTRAZEN|ISIN: INE203A01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 18, 15:51
915.00
-12.1 (-1.31%)
VOLUME 685
LIVE
NSE
Aug 18, 15:40
910.35
-17.9 (-1.93%)
VOLUME 13,170
Download Annual Report PDF Format 2016 | 2015 | 2014 | 2013 | 2012 | 2011

Quarterly Results of AstraZeneca Pharma

------------------- in Rs. Cr. -------------------
Jun '17 Mar '17 Dec '16 Sep '16 Jun '16
Net Sales/Income from operations 127.48 110.95 141.12 136.14 138.09
Other Operating Income -- 0.63 9.16 2.02 1.45
Total Income From Operations 127.48 111.58 150.29 138.17 139.54
EXPENDITURE
Consumption of Raw Materials 5.48 5.30 2.44 3.06 3.20
Purchase of Traded Goods 58.44 28.08 35.67 27.62 50.78
Increase/Decrease in Stocks -18.77 4.32 8.93 13.49 -9.23
Power & Fuel -- -- -- -- --
Employees Cost 34.94 36.07 38.12 46.96 42.33
Depreciation 3.71 3.68 4.02 4.06 4.07
Excise Duty -- -- -- -- --
Admin. And Selling Expenses 11.86 -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 29.32 42.55 50.18 43.82 36.50
P/L Before Other Inc. , Int., Excpt. Items & Tax 2.51 -8.42 10.92 -0.84 11.90
Other Income 4.65 6.43 9.83 1.82 1.56
P/L Before Int., Excpt. Items & Tax 7.16 -1.99 20.75 0.98 13.46
Interest -- -- -- -- --
P/L Before Exceptional Items & Tax 7.16 -1.99 20.75 0.98 13.46
Exceptional Items -- -- -- -- --
P/L Before Tax 7.16 -1.99 20.75 0.98 13.46
Tax 1.37 0.88 4.79 0.19 2.90
P/L After Tax from Ordinary Activities 5.80 -2.88 15.96 0.79 10.57
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 5.80 -2.88 15.96 0.79 10.57
Equity Share Capital 5.00 5.00 5.00 5.00 5.00
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 2.32 -1.15 6.39 0.31 4.23
Diluted EPS 2.32 -1.15 6.39 0.31 4.23
EPS After Extra Ordinary
Basic EPS 2.32 -1.15 6.39 0.31 4.23
Diluted EPS 2.32 -1.15 6.39 0.31 4.23
Public Share Holding
No Of Shares (Crores) -- -- -- -- --
Share Holding (%) -- -- -- -- --
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
Notes
Source : Dion Global Solutions Limited
Quick Links for astrazenecapharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.